We are lightening in a stock of rally that has become too big in our portfolio
The sale also occurs when our trusted impulse indicator moved more to the overcompra territory.
Sartorius AG
These four stocks of anti-obesity drugs could skyrocket, says Berenberg
The anti-obesity drug market is expected to remain in the spotlight this year after a bumper 2023 for weight loss…